Biphasic anaphylaxis is a recurrence of anaphylactic symptoms that strikes hours after an initial allergic reaction has fully resolved, without any new exposure to the allergen. The second wave can involve the skin, airways, cardiovascular system, or gut, and it catches people off guard because they genuinely felt better in between. Estimates of how often it happens vary widely, from less than 1% to 20% of anaphylaxis episodes, largely because researchers have defined it differently over the years.1PubMed. Epidemiology, Risk Factors, and Management of Biphasic Anaphylaxis The possibility of this delayed return is the main reason emergency departments keep you under observation after treating an anaphylactic reaction.
How Biphasic Anaphylaxis Differs from a Lingering Reaction
The defining feature is a clear symptom-free window. During a standard anaphylactic episode, symptoms build, get treated, and fade. In a biphasic course, the person recovers fully, sometimes feeling completely normal for several hours, and then a second round of symptoms begins with no new allergen contact.2PubMed Central. Incidence and timing of biphasic anaphylactic reactions: a retrospective cohort study That gap between the two phases is what separates biphasic anaphylaxis from protracted anaphylaxis, where symptoms simply never fully go away and can drag on for days.
A Delphi consensus study involving allergy, emergency medicine, and immunology specialists sought to clarify these distinctions because earlier research often lumped all returning symptoms, even mild ones like a rash, under the “biphasic anaphylaxis” label. The panel argued that a second-phase reaction should only count as true biphasic anaphylaxis if the recurring symptoms themselves meet formal anaphylaxis criteria, not just if some hives reappear.3Journal of Allergy and Clinical Immunology. Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study This distinction matters because mild returning symptoms carry a very different clinical weight than a full-blown second anaphylactic episode.
In one hospital study of 114 anaphylaxis inpatients, about 6% experienced a biphasic course and another 3.5% had protracted reactions that lasted two to eight days. Among the biphasic cases, most second-phase symptoms were skin-related and mild; only one of seven cases was classified as severe.4PubMed Central. Incidence and characteristics of biphasic and protracted anaphylaxis: evaluation of 114 inpatients That pattern shows up repeatedly in the literature: when the second phase does happen, it tends to be less dangerous than the first, though dangerous exceptions exist.
When the Second Phase Hits
The timing of the second wave is frustratingly unpredictable. Literature reviews place the mean onset of the second phase at roughly eight hours after the initial reaction, but documented cases range from about one hour to as long as 72 hours later, with most occurring beyond the eight-hour mark.5PubMed Central. Post-anaphylaxis observation in the ED: a decade of data challenging the traditional 24-hour rule A systematic review that identified 84 patients with true biphasic reactions found a mean time to the second phase of about eight hours, with no meaningful difference between children and adults.6PubMed Central. Biphasic anaphylaxis: a systematic review of the literature
That eight-hour average is the figure most clinicians work with, but it hides a lot of scatter. Some second phases appear within two to three hours, while others sneak up overnight. The wide window is precisely what makes observation decisions so difficult. If nearly all biphasic reactions happened within four hours, everyone could go home after that point. Instead, the second wave’s tendency to arrive well past the typical emergency department stay creates a gray zone that physicians and patients have to navigate together.
Who Is Most at Risk
Researchers have identified several factors that raise the odds of a biphasic course. A history of previous anaphylaxis roughly triples the risk, and when the trigger of the initial reaction cannot be identified, the odds roughly double.7PubMed. Further Evaluation of Factors That May Predict Biphasic Reactions in Emergency Department Anaphylaxis Patients Delayed epinephrine treatment shows up as a risk factor in multiple studies. In one prospective cohort, the median time from symptom onset to the first epinephrine dose was 78 minutes for patients who went on to have biphasic reactions, compared to 45 minutes for those who did not. Waiting more than 30 minutes to give epinephrine was associated with more than three times the odds of a biphasic course.8PubMed. Biphasic Reactions in Emergency Department Anaphylaxis Patients: A Prospective Cohort Study
A large registry-based analysis found that more severe initial reactions, reactions involving multiple organ systems, and specific triggers like peanuts and tree nuts also increased the chances of a second phase. Exercise as a cofactor, a longer delay between allergen contact and the start of symptoms, and a history of chronic hives were additional risk factors.9The Journal of Allergy and Clinical Immunology: In Practice. Factors Associated with Biphasic Anaphylaxis: Findings from the Anaphylaxis Registry One study of anaphylaxis triggered by iodinated contrast dye used in imaging scans found that when the initial reaction lasted longer than 40 minutes, the odds of a biphasic reaction rose sharply.10PubMed. Biphasic and protracted anaphylaxis to iodinated contrast media
The thread connecting these risk factors is that a more intense or prolonged initial immune response seems to set the stage for a delayed encore. Delayed epinephrine probably factors in because longer-running initial reactions produce a greater inflammatory cascade that takes longer to fully shut down. None of these risk factors are perfectly predictive, though. Plenty of severe initial reactions resolve cleanly, and some mild ones end up biphasic.
The Corticosteroid Question
For decades, giving steroids like methylprednisolone or prednisone during or after anaphylaxis was considered standard practice, partly on the assumption that they would dampen late-phase inflammation and prevent biphasic reactions. The evidence for this has eroded substantially.
A propensity score-matched study compared hospitalized anaphylaxis patients who received glucocorticoids with those who did not. The biphasic reaction rate was almost identical: about 10.7% in the steroid group versus 10.5% in the control group.11PubMed Central. Glucocorticoids and Rates of Biphasic Reactions in Patients with Adrenaline-Treated Anaphylaxis: A Propensity Score Matching Analysis An earlier emergency department study found a similar lack of benefit, with clinically important biphasic reactions actually slightly more common in the steroid group.12PubMed. Emergency Department Corticosteroid Use for Allergy or Anaphylaxis Is Not Associated With Decreased Relapses A review of the broader evidence concluded that because steroids carry their own side effects and show no compelling benefit for preventing biphasic reactions, their routine use in anaphylaxis is not warranted.13PubMed. Do Corticosteroids Prevent Biphasic Anaphylaxis?
This represents a real shift from how many emergency departments have historically practiced. Steroids are still sometimes given for other reasons during severe allergic episodes, but their use specifically to ward off a biphasic reaction is increasingly seen as unsupported habit rather than evidence-based medicine. That said, clinical guidelines have been slow to formally drop the recommendation, so you may still receive steroids during an anaphylactic event depending on where you are treated.
How Long Should You Stay for Observation
The traditional recommendation is to observe anaphylaxis patients for four to six hours in the emergency department after their symptoms have completely resolved.14PubMed. Biphasic anaphylaxis: A review of the literature and implications for emergency management But given that the mean onset of the second phase is around eight hours, and some biphasic reactions arrive much later, this window catches only a fraction of potential cases. The question of whether to extend observation to 12 or even 24 hours has been debated vigorously.
The economics complicate things. A simulation study found that extending observation from one hour to six hours cost roughly $62,000 for each additional case of biphasic anaphylaxis caught from a healthcare-sector perspective. When observation periods were extended even further, the costs climbed steeply relative to the number of biphasic cases actually detected.15PubMed Central. Simulation of Health and Economic Benefits of Extended Observation of Resolved Anaphylaxis Health-economic analyses broadly conclude that prolonged observation of patients whose symptoms have fully resolved rarely makes financial sense at a population level.16PubMed. Cost-effective care in anaphylaxis prevention and management
This does not mean observation is pointless. It means a blanket six-to-24-hour hold for every anaphylaxis patient is a blunt instrument. Some clinicians are moving toward risk-stratified discharge: patients with risk factors for biphasic reactions, such as a severe initial reaction, delayed epinephrine, or an unknown trigger, get longer observation, while those who had a mild, quickly treated reaction with a known cause may safely go home sooner. The trouble is that no validated scoring system exists yet to make that decision reliably, so much of it still comes down to clinical judgment.
What to Do After You Leave the Emergency Department
Regardless of how long you are observed, the consensus is clear on one point: anyone discharged after anaphylaxis should leave with an epinephrine auto-injector and clear instructions on how and when to use it.17PubMed Central. Outpatient Emergencies: Anaphylaxis This is especially relevant for biphasic risk because the second phase, if it arrives, will likely do so at home or wherever the person has gone after discharge. Having epinephrine on hand turns a potentially dangerous situation into a manageable one.
Beyond the auto-injector, an action plan matters. That means knowing what to watch for: returning hives, throat tightness, difficulty breathing, a drop in blood pressure, abdominal cramping, or any combination of symptoms affecting more than one body system. If those symptoms appear in the hours after leaving the hospital, the instruction is always to use the auto-injector and call for emergency help immediately, not to wait and see whether the symptoms worsen. The second phase can escalate just as the first one did.
You should also follow up with an allergist. An emergency department treats the crisis, but allergists are the ones who can investigate the trigger, arrange for skin testing or blood panels, and design a long-term management strategy. If the cause of the initial reaction was never identified, that follow-up becomes even more important because unknown triggers are associated with a higher biphasic risk, and they leave you unable to avoid re-exposure.
Confirming the Reaction Happened
One of the complications of biphasic anaphylaxis is that by the time the second phase arrives, the patient may not be in a clinical setting. This makes documentation and confirmation harder. Serum tryptase, a protein released by mast cells during anaphylaxis, is the primary biomarker used to confirm that an anaphylactic reaction occurred. Tryptase levels peak roughly one to two hours after the event and then decline with a half-life of about two hours, meaning the window for a confirmatory blood draw is relatively narrow.18JCI Insight. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis
For the initial reaction, this is usually manageable since the patient is already in a hospital. For a biphasic reaction that occurs at home eight or twelve hours later, tryptase levels may have risen and fallen again before the person can get a blood draw. Practically speaking, clinicians often have to rely on a combination of reported symptoms and the clinical context, especially the timing relative to the first episode, to classify a second reaction as biphasic.
Biphasic Reactions in Children
Children are not spared from biphasic anaphylaxis, and the timing and frequency look similar to adults. The systematic review mentioned earlier found that the mean time to the second phase was comparable between pediatric and adult patients, both clustering around eight hours.6PubMed Central. Biphasic anaphylaxis: a systematic review of the literature Food allergies, particularly to peanuts and tree nuts, are among the most common triggers of anaphylaxis in children, and those same triggers are independently associated with higher biphasic risk.9The Journal of Allergy and Clinical Immunology: In Practice. Factors Associated with Biphasic Anaphylaxis: Findings from the Anaphylaxis Registry
For parents, this creates an especially anxious situation. A child treated for anaphylaxis at a hospital, seemingly recovered, and sent home still faces a window of several hours during which symptoms could return. Schools, daycares, and other settings where children spend time away from their parents add another layer of complexity. Making sure that any caregiver who might be present during the risk window knows how to recognize anaphylaxis and use an auto-injector is a practical step that matters more than any observation protocol.
The Psychological Aftermath
The possibility of a second wave, even after you feel fine, introduces a specific kind of anxiety that goes beyond ordinary allergy management. A systematic review of quality-of-life outcomes in adults with anaphylaxis found that fear and emotional burden from previous episodes drove avoidant behaviors and social withdrawal as people tried to reduce the risk of experiencing anaphylaxis again.19PubMed Central. Quality of life and psychological wellbeing of adults with anaphylaxis: a mixed method systematic review When people know that their body can mount a second attack even after the first one has been treated and resolved, that fear can intensify.
Some patients describe a hypervigilance that extends well past the 72-hour biphasic window. Every mild itch, throat tickle, or stomach cramp gets scanned as a potential sign of returning anaphylaxis. Over time, this kind of monitoring can be exhausting and socially limiting: people avoid restaurants, travel, or gatherings where they feel they cannot quickly access medical care. Addressing this anxiety, sometimes with the help of a therapist experienced in chronic illness, is a legitimate part of long-term anaphylaxis management that often gets overlooked in clinical encounters focused on trigger avoidance and medication prescriptions.
Why the Numbers Are So Hard to Pin Down
The reported incidence of biphasic anaphylaxis ranges from under 1% to 20%, and that range has persisted across decades of research.1PubMed. Epidemiology, Risk Factors, and Management of Biphasic Anaphylaxis One well-conducted emergency department study placed the rate at about 7%, with roughly 5% of all anaphylaxis visits involving a clinically significant biphasic reaction.20The Journal of Allergy and Clinical Immunology: In Practice. What Is Biphasic Anaphylaxis? The Delayed Allergic Reaction Prospective studies tend to report rates closer to 9%.6PubMed Central. Biphasic anaphylaxis: a systematic review of the literature
Much of this scatter comes down to definitions. Some studies counted any returning symptom as biphasic, including a reappearing rash that would not meet formal anaphylaxis criteria. Others required the second phase to involve true anaphylaxis with multi-organ involvement. Observation protocols differ too. Studies that discharged patients early and relied on phone follow-up may have missed mild biphasic reactions that people treated at home. Studies with mandatory 24-hour holds naturally caught more. Until the field settles on a single, consistently applied definition, the true frequency will remain a range rather than a point estimate.
That uncertainty is frustrating, but it also provides some practical reassurance. Even at the high end of estimates, the large majority of anaphylaxis episodes do not produce a biphasic reaction. When one does occur, it is more often milder than the initial episode. The severe, life-threatening biphasic events that dominate popular fear are real but uncommon even within the already uncommon subset of biphasic cases. Knowing this can help calibrate the post-reaction vigilance period without spiraling into panic.